Developmental plasticity shapes synaptic phenotypes of autism-associated neuroligin-3 mutations in the calyx of held

Molecular Psychiatry

Volumn 22, Issue 10, 2017, Pages 1483-1491

  Zhang, B ^a   Seigneur, E ^a   Wei, P ^b   Gokce, O ^a   Morgan, J ^b   Sudhof T C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBELLIN 1; NEUREXIN; NEUROLIGIN; NEUROLIGIN 3; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTISM; CALYX OF HELD; CELL MANIPULATION; CHROMOSOME HIGH RESOLUTION BANDING ANALYSIS; COMPENSATION; CONTROLLED STUDY; DEVELOPMENTAL PLASTICITY; GENE EXPRESSION; GENE FUNCTION; GENE KNOCK-IN; GENE MUTATION; GLUTAMATERGIC SYNAPSE; MOUSE; NONHUMAN; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; ANIMAL; DISEASE MODEL; GENETICS; HIPPOCAMPUS; KNOCKOUT MOUSE; METABOLISM; MUTATION; NERVE CELL; NERVE CELL PLASTICITY; PHYSIOLOGY; SYNAPSE; TRAPEZOID BODY;

ANIMALS; AUTISTIC DISORDER; CELL ADHESION MOLECULES, NEURONAL; DISEASE MODELS, ANIMAL; GENE KNOCK-IN TECHNIQUES; HIPPOCAMPUS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUTATION; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEURONS; SYNAPSES; SYNAPTIC TRANSMISSION; TRAPEZOID BODY;

EID: 84991037537     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2016.157     Document Type: Article

References (72)

1. Südhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008; 455: 903–911.
2. Siddiqui TJ, Pancaroglu R, Kang Y, Rooyakkers A, Craig AM. LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. J Neurosci 2010; 30: 7495–7506.
3. Yuzaki M. Cbln1 and its family proteins in synapse formation and maintenance. Curr Opin Neurobiol 2011; 21: 215–220.
4. Song JY, Ichtchenko K, Südhof TC, Brose N. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc Natl Acad Sci USA 1999; 96: 1100–1105.
5. Varoqueaux F, Jamain S, Brose N. Neuroligin 2 is exclusively localized to inhibitory synapses. Eur J Cell Biol 2004; 83: 449–456.
6. Budreck EC, Scheiffele P. Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. Eur J Neurosci 2007; 26: 1738–1748.
7. Hoon M, Soykan T, Falkenburger B, Hammer M, Patrizi A, Schmidt K-F et al. Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. Proc Natl Acad Sci USA 2011; 108: 3053–3058.
8. Takács VT, Freund TF, Nyiri G. Neuroligin 2 is expressed in synapses established by cholinergic cells in the mouse brain. PLoS ONE 2013; 8: e72450.
9. Rothwell PE, Fuccillo MV, Maxeiner S, Hayton SJ, Gokce O, Lim BK et al. Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell 2014; 158: 198–212.
10. Liang J, Xu W, Hsu Y-T, Yee A, Chen L, Südhof T. Conditional neuroligin-2 knockout in adult medial prefrontal cortex links chronic changes in synaptic inhibition to cognitive impairments. Mol Psychiatry 2015; 20: 850–859.
11. Zhang B, Chen LY, Liu X, Maxeiner S, Lee S-J, Gokce O et al. Neuroligins sculpt cerebellar purkinje-cell circuits by differential control of distinct classes of synapses. Neuron 2015; 87: 781–796.
12. Jamain S, Quach H, Betancur C, Råstam M, Colineaux C, Gillberg IC et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34: 27–29.
13. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 williams syndrome region, are strongly associated with autism. Neuron 2011; 70: 863–885.
14. Levy D, Ronemus M, Yamrom B, Lee Yha, Leotta A, Kendall J et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 2011; 70: 886–897.
15. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007; 318: 71–76.
16. Etherton M, Földy C, Sharma M, Tabuchi K, Liu X, Shamloo M et al. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc Natl Acad Sci USA 2011; 108: 13764–13769.
17. Földy C, Malenka RC, Südhof TC. Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 2013; 78: 498–509.
18. Hirai H, Pang Z, Bao D, Miyazaki T, Li L, Miura E et al. Cbln1 is essential for synaptic integrity and plasticity in the cerebellum. Nat Neurosci 2005; 8: 1534–1541.
19. Mizuno Y, Takahashi K, Totsune K, Ohneda M, Konno H, Murakami O et al. Decrease in cerebellin and corticotropin-releasing hormone in the cerebellum of olivopontocerebellar atrophy and Shy-Drager syndrome. Brain Res 1995; 686: 115–118.
20. Boghosian-Sell L, Comings DE, Overhauser J. Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3. Am J Hum Genet 1996; 59: 999–1005.
21. Abalkhail H, Mitchell J, Habgood J, Orrell R, de Belleroche J. A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2. Am J Hum Genet 2003; 73: 383–389.
22. Clarke Ra, Lee S, Eapen V. Pathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism. Transl Psychiatry 2012; 2: e163.
23. Uemura T, Lee SJ, Yasumura M, Takeuchi T, Yoshida T, Ra M et al. Trans-synaptic interaction of GluRδ2 and neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell 2010; 141: 1068–1079.
24. Matsuda K, Miura E, Miyazaki T, Kakegawa W, Emi K, Narumi S et al. Cbln1 is a ligand for an orphan glutamate receptor delta2, a bidirectional synapse organizer. Science (80-) 2010; 328: 363–368.
25. Kusnoor SV, Parris J, Muly EC, Morgan JI, Deutch a Y. Extracerebellar role for Cerebellin1: modulation of dendritic spine density and synapses in striatal medium spiny neurons. J Comp Neurol 2010; 518: 2525–2537.
26. Miura E, Iijima T, Yuzaki M, Watanabe M. Distinct expression of Cbln family mRNAs in developing and adult mouse brains. Eur J Neurosci 2006; 24: 750–760.
27. Wei P, Smeyne RJ, Bao D, Parris J, Morgan JI. Mapping of Cbln1-like immunoreactivity in adult and developing mouse brain and its localization to the endolysosomal compartment of neurons. Eur J Neurosci 2007; 26: 2962–2978.
28. Yu WM, Goodrich LV. Morphological and physiological development of auditory synapses. Hear Res 2014; 311: 3–16.
29. Borst JGG, Soria van Hoeve J. The calyx of held synapse: from model synapse to auditory relay. Annu Rev Physiol 2012; 74: 199–224.
30. Nakamura PA, Cramer KS. Formation and maturation of the calyx of Held. Hear Res 2011; 276: 70–78.
31. Wang L-Y, Fedchyshyn MJ, Yang Y-M. Action potential evoked transmitter release in central synapses: insights from the developing calyx of Held. Mol Brain 2009; 2: 36.
32. Takahashi T. Strength and precision of neurotransmission at mammalian presynaptic terminals. Proc Jpn Acad Ser B Phys Biol Sci 2015; 91: 305–320.
33. von Gersdorff H, Borst JGG. Short-term plasticity at the calyx of held. Nat Rev Neurosci 2002; 3: 53–64.
34. Holcomb PS, Hoffpauir BK, Hoyson MC, Jackson DR, Deerinck TJ, Marrs GS et al. Synaptic inputs compete during rapid formation of the calyx of held: a new model system for neural development. J Neurosci 2013; 33: 12954–12969.
35. Xiao L, Michalski N, Kronander E, Gjoni E, Genoud C, Knott G et al. BMP signaling specifies the development of a large and fast CNS synapse. Nat Neurosci 2013; 16: 856–864.
36. Abdul-Latif ML, Salazar JAA, Marshak S, Dinh ML, Cramer KS. Ephrin-A2 and ephrin-A5 guide contralateral targeting but not topographic mapping of ventral cochlear nucleus axons. Neural Dev 2015; 10: 27.
37. Yang Y-M, Fedchyshyn MJ, Grande G, Aitoubah J, Tsang CW, Xie H et al. Septins regulate developmental switching from microdomain to nanodomain coupling of Ca(2+) influx to neurotransmitter release at a central synapse. Neuron 2010; 67: 100–115.
38. Michalski N, Babai N, Renier N, Perkel DJ, Ch??dotal A, Schneggenburger R. Robo3-driven axon midline crossing conditions functional maturation of a large commissural synapse. Neuron 2013; 78: 855–868.
39. Aoto J, Martinelli DC, Malenka RC, Tabuchi K, Südhof TC. Presynaptic neurexin-3 alternative splicing trans-synaptically controls postsynaptic AMPA receptor trafficking. Cell 2013; 154: 75–88.
40. Zhang B, Sun L, Yang Y-M, Huang H-P, Zhu F-P, Wang L et al. Action potential bursts enhance transmitter release at a giant central synapse. J Physiol 2011; 589: 2213–2227.
41. Acuna C, Liu X, Gonzalez A, Südhof TC. RIM-BPs mediate tight coupling of action potentials to Ca2+-triggered neurotransmitter release. Neuron 2015; 87: 1234–1247.
42. Forsythe ID, Barnes-Davies M. The binaural auditory pathway: membrane currents limiting multiple action potential generation in the rat medial nucleus of the trapezoid body. Proc Biol Sci 1993; 251: 143–150.
43. Schneggenburger R, Meyer AC, Neher E. Released fraction and total size of a pool of immediately available transmitter quanta at a calyx synapse. Neuron 1999; 23: 399–409.
44. Etherton MR, Tabuchi K, Sharma M, Ko J, Südhof TC. An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptormediated synaptic transmission in hippocampus. EMBO J 2011; 30: 2908–2919.
45. Chanda S, Aoto J, Lee S-J, Wernig M, Südhof TC. Pathogenic mechanism of an autism-associated neuroligin mutation involves altered AMPA-receptor trafficking. Mol Psychiatry 2015; 21: 169–177.
46. Voiculescu O, Charnay P, Schneider-Maunoury S. Expression pattern of a Krox-20/Cre knock-in allele in the developing hindbrain, bones, and peripheral nervous system. Genesis 2000; 26: 123–126.
47. De S, Shuler CF, Turman JE. The ontogeny of Krox-20 expression in brainstem and cerebellar neurons. J Chem Neuroanat 2003; 25: 213–226.
48. Han Y, Kaeser PS, Südhof TC, Schneggenburger R. RIM determines Ca2+ channel density and vesicle docking at the presynaptic active zone. Neuron 2011; 69: 304–316.
49. Yang Y-M, Aitoubah J, Lauer AM, Nuriya M, Takamiya K, Jia Z et al. GluA4 is indispensable for driving fast neurotransmission across a high-fidelity central synapse. J Physiol 2011; 589: 4209–4227.
50. Huguet G, Ey E, Bourgeron T. The genetic landscapes of autism spectrum disorders. Annu Rev Genomics Hum Genet 2013; 14: 191–213.
51. Ichtchenko K, Nguyen T, Südhof TC. Structures, alternative splicing, and neurexin binding of multiple neuroligins. J Biol Chem 1996; 271: 2676–2682.
52. Chih B, Gollan L, Scheiffele P. Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex. Neuron 2006; 51: 171–178.
53. Comoletti D, Flynn RE, Boucard AA, Demeler B, Schirf V, Shi J et al. Gene selection, alternative splicing, and post-translational processing regulate neuroligin selectivity for β-neurexins. Biochemistry 2006; 45: 12816–12827.
54. Lilley BN, Krishnaswamy A, Wang Z, Kishi M, Frank E, Sanes JR. SAD kinases control the maturation of nerve terminals in the mammalian peripheral and central nervous systems. Proc Natl Acad Sci USA 2014; 111: 1138–1143.
55. Kolson DR, Wan J, Wu J, Dehoff M, Brandebura AN, Qian J et al. Temporal patterns of gene expression during calyx of held development. Dev Neurobiol 2016; 76: 166–189.
56. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999; 283: 1482–1488.
57. Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 10: 8192–8192.
58. McCarthy SE, Gillis J, Kramer M, Lihm J, Yoon S, Berstein Y et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry 2014; 19: 652–658.
59. Guilmatre A, Huguet G, Delorme R, Bourgeron T. The emerging role of SHANK genes in neuropsychiatric disorders. Dev Neurobiol 2014; 74: 113–122.
60. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013; 45: 984–994.
61. Group C, Consortium PG. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371–1379.
62. Kenny EM, Cormican P, Furlong S, Heron E, Kenny G, Fahey C et al. Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol Psychiatry 2014; 19: 872–879.
63. Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet Part C Semin Med Genet 2003; 123C: 48–58.
64. Maier W, Lichtermann D, Minges J, Hallmayer J, Heun R, Benkert O et al. Continuity and discontinuity of affective disorders and schizophrenia: Results of a controlled family study. Arch Gen Psychiatry 1993; 50: 871–883.
65. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234–239.
66. Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N. Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry 2009; 48: 10–18.
67. King BH, Lord C. Is schizophrenia on the autism spectrum? Brain Res 2011; 1380: 34–41.
68. Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J et al. Copy number variants in schizophrenia: Confirmation of five previous finding sand new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 2011; 168: 302–316.
69. Ronald A, Simonoff E, Kuntsi J, Asherson P, Plomin R. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. J Child Psychol Psychiatry Allied Discip 2008; 49: 535–542.
70. Rommelse NNJ, Franke B, Geurts HM, Hartman CA, Buitelaar JK. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 2010; 19: 281–295.
71. Lichtenstein P, Carlström E, Råstam M, Gillberg C, Anckarsäter H. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry 2010; 167: 1357–1363.
72. Williams NM, Franke B, Mick E, Anney RJL, Freitag CM, Gill M et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: The role of rare variants and duplications at 15q13.3. Am J Psychiatry 2012; 169: 195–204.